Darrin Miles
Vorstandsvorsitzender bei Nested Therapeutics, Inc.
Profil
Darrin Miles is currently the Chief Executive Officer & Director at Nested Therapeutics, Inc. Prior to this, he worked as the Chief Commercial Officer at Agios Pharmaceuticals, Inc. from 2015 to 2021.
He completed his undergraduate degree at Cornell University.
Aktive Positionen von Darrin Miles
Unternehmen | Position | Beginn |
---|---|---|
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Darrin Miles
Unternehmen | Position | Ende |
---|---|---|
AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06.12.2021 |
Ausbildung von Darrin Miles
Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Commercial Services |